Category: Infectious Diseases
Wohl Addresses NC’s Partial Reopening on WRAL
David Wohl, MD (Credit: WRAL News) David Wohl, MD, professor of medicine in the division of infectious diseases, addresses a partial reopening in North Carolina in a WRAL interview. “This is a hard train to stop so we haven’t all been able to stay at home to stop the transmission completely, from person to person, but we’ve made great strides,” Wohl said. “I think it’s going to s … Read more
Weber Discusses Possibilities Of Second COVID Wave
David Weber, MD, MPH David Weber, MD, MPH, medical director of hospital epidemiology (infection prevention), talked with ABC 11 News about new concerns for a second wave. The story reports that Weber “believes it’s not a question of when we’ll have more peaks but how big they are.” Weber, a professor of medicine in the division of infectious diseases, says “we’re not going to kno … Read more
Q&A With David Wohl on COVID-19 and HIV
David Wohl, MD (Credit: TPAN) David Wohl, MD, professor of medicine in the division of infectious diseases, offered insight into the current pandemic based on what he witnessed during the Ebola epidemic in an interview with Test Positive Aware Network (TPAN)’s Positively Aware. “Right now, what holds for people living without HIV holds for people living with HIV,” Wohl said in th … Read more
Adimora Addresses Concern For the Effects of COVID-19 Among People Living With HIV
Adaora A. Adimora, MD, MPH Ada Adimora, MD, MPH, the Sarah Graham Kenan Distinguished Professor of Medicine in the division of infectious diseases, expressed concern in an interview with Healio Infectious Disease News, about the lack of studies regarding the specific impact of effect of COVID-19 in people living with HIV (PLWH). 鈥淧eople with well-controlled HIV have an聽excellent … Read more
Schranz Receives Grant from NIH National Institute on Drug Abuse
Asher Schranz, MD, MPH Asher Schranz, MD, MPH, assistant professor of medicine in the division of infectious diseases, has received a grant from the NIH National Institute on Drug Abuse (NIDA) for the project “Drug-use associated infective endocarditis: Post-hospitalization outcomes and patient treatment preferences.” Schranz’s research is broadly focused on the intersection of i … Read more
Novel Primary Care Model Promotes Lifelong Comprehensive Care for People Living with HIV
Shana Ratner, MD, associate professor in the division of general medicine, and section chief for education and clinical practice, announces a novel collaboration with the division of infectious diseases that includes a multidisciplinary primary care clinic to serve people living with HIV. The new model lays the groundwork for multidisciplinary care in advance of the move to Easto … Read more
Cohen Comments On Fauci and Birx As National COVID-19 Advisors
Myron Cohen, MD Myron Cohen, MD, professor of medicine in the division of infectious diseases, has known NIH Director Anthony S. Fauci, MD, and Deborah Birx, MD, the White House Coronavirus Response Coordinator, since the 1980s, he told the Washington Post in a recent interview. Speaking on their partnership as scientists and public health officials, he emphasized that “the pair … Read more
Wohl Discusses Testing Shortages With New York Post
David Wohl, MD David Wohl, MD, professor of medicine in the division of infectious diseases, says the signs were clear in early February and that was the time to ramp up, in the New York Post article “Rich and famous get COVID-19 test but average people can’t.”聽 Wohl expresses his concerns about “a serious lack of preparation and coordination鈥 in overall response. Find the articl … Read more
Department of Medicine Grants & Funding: March 1-March 31, 2020
Division of Hematology and Oncology Nigel Key, MD, ChB, CRCP, received a $180,000 grant for the聽鈥淓valuating the Mechanism of Emicizumab-related Thrombotic Microangiopathy.鈥 Tracy L. Rose,聽MD MPH, received an聽NCI K08 grant for the project聽鈥淪elective histone deacetylase inhibition with entinostat to enhance the anti-tumor immune response to immune checkpoint inhibition in urothelia … Read more
Weber Answers Coronavirus Questions on People’s Pharmacy
David Weber, MD, MPH David Weber, MD, MPH, professor of medicine in the division of infectious diseases, answered questions about COVID-19 on聽The People’s Pharmacy with Joe and Terry Graedon. He explained a cytokine storm and the immune reaction to the virus. He also discussed drugs being considered for treatment. The March 26 podcast can be accessed here.
ViiV Healthcare, 黑料网-Chapel Hill announce five-year, $20 million renewal of HIV cure partnership
David Margolis, MD, Director of the 黑料网 HIV Cure Center (Credit: Jon Gardiner) This unique public-private collaboration provides funding for HIV Cure Center and Qura Therapeutics, the joint venture that brings academic and pharmaceutical research scientists together for the goal of curing people with HIV. David Margolis, MD, is the director of the 黑料网 Cure Center. 鈥淲ithout the Qu … Read more
IHQI Improvement Scholars Announced, Five in Medicine
Mildred Kwan The Institute for Healthcare Quality Improvement (IHQI) has announced projects that will be supported through IHQI鈥檚 Improvement Scholars Program. Half of these scholars are members of the 黑料网 Department of Medicine, and they include the following. Mildred Kwan, MD PhD, with lead Renae Boerneke, PharmD, BCPS, CPP — Reducing the Healthcare Utilization of Broad … Read more